Michelle Staben Wobker serves as the Associate Director of Program Management for Biosimilars at Civica Rx, where her extensive expertise in chemical engineering and project management plays a pivotal role in advancing the organization's mission to enhance global health. With over 15 years of experience...
Michelle Staben Wobker serves as the Associate Director of Program Management for Biosimilars at Civica Rx, where her extensive expertise in chemical engineering and project management plays a pivotal role in advancing the organization's mission to enhance global health. With over 15 years of experience in Chemistry, Manufacturing, and Controls (CMC) development, Michelle leads multi-functional teams through the complex landscape of biosimilar development, from initial research and regulatory approval to manufacturing and commercialization. Her collaborative leadership style fosters strong relationships across diverse functions, including R&D, Quality, Regulatory, Supply Chain, and Commercial Operations, ensuring that projects are executed efficiently and effectively.
At Civica Rx, Michelle is currently spearheading key projects aimed at expanding access to affordable biosimilars, addressing critical gaps in the healthcare system. Her proficiency in drug development and process engineering allows her to navigate the intricacies of biotechnology, ensuring that each project aligns with regulatory standards while meeting the needs of patients and healthcare providers. By leveraging her PMP certification and matrix leadership skills, she guides her teams through the challenges of program development, data management, and operational efficiency, ultimately driving successful outcomes in a mission-driven environment.
Michelle's commitment to solving tough challenges in global health is evident in her strategic approach to project management and her ability to inspire cross-functional collaboration. As she continues to lead innovative initiatives at Civica Rx, her work not only advances the field of biosimilars but also contributes to a more equitable healthcare landscape for all.
